Navigation Links
New Reproductive Support Dietary Supplement, Pregnitude™, Now Available For Women Having Difficulty Conceiving
Date:5/7/2012

WEST ORANGE, N.J., May 7, 2012 /PRNewswire/ -- A new non-prescription Reproductive Support Dietary Supplement, Pregnitude™, which contains myo-inositol (2 g), plus folic acid (200 mcg), is now available for women who are having difficulty conceiving, Everett Laboratories announced today. In clinical studies, Pregnitude has been shown to help support ovulation function and menstrual cycle regularity as well as support the quality of a woman's eggs.

"Everett Labs is proud to make this new, important contribution to women's health. With Pregnitude, we're thrilled to provide a new option to support women who are having difficulty conceiving. We are confident that obstetricians and gynecologists around the country will find this a valuable alternative for women to support the ovulation frequency, regularity and quality of eggs," said Lucas Sigman, Chief Executive Officer, Everett Laboratories, Inc.

Myo-inositol is a naturally occurring substance produced in the human body that belongs to the vitamin B complex group and is found naturally in many foods such as fruits, cereals with high bran content, nuts and beans. Both myo-inositol and folic acid are considered to be important nutrients for women who are trying to become pregnant.

Approximately 6.1 million women in the United States have difficulty getting pregnant, according to the Centers for Disease Control and Prevention (CDC). 

"There is a tremendous need for support of couples having difficulty conceiving. They're often left frustrated and anxious, and the stress can compound the problem. Pregnitude can help support ovulation function, menstrual cycle regularity, and quality of eggs during this difficult time," said Scott Eder, M.D., Medical Director, Everett Laboratories and a board-certified obstetrician and gynecologist who practices in Lawrenceville, NJ.

Pregnitude is a powder formulation that is mixed with water and taken twice a day, in the morning and evening. It is available without a prescription at most major retail pharmacies and can be found behind the pharmacy counter. Consumers can also order Pregnitude online, at www.pregnitude.com

Clinical Trials with Myo-inositol in Combination with Folic Acid

Controlled clinical studies have demonstrated that supplementation with myo-inositol has a beneficial effect on ovulatory function, improving ovulation frequency, promoting menstrual cycle regularity and improving the quality of oocytes, or immature eggs.

"The results of the clinical trials with myo-inositol supplementation are particularly encouraging in supporting ovarian function. We are thrilled to provide another tool to support women wishing to become pregnant," said Dr. Eder.

Side effects and Who Should Not Use Pregnitude

Pregnitude is generally well tolerated. Women may experience gastrointestinal effects such as nausea and diarrhea when taken at high doses. Pregnitude should not be taken by anyone with a known hypersensitivity to either myo-inositol or folic acid. Folic acid should not be taken by anyone with untreated or uncomplicated pernicious anemia and those with anaphylactic sensitivity to folic acid. In addition, high doses of myo-inositol may have additive effects when taken concurrently with selective serotonin reuptake inhibitor (SSRI) and selective serotonin norepinephrine reuptake inhibitor (SNRI) antidepressant medications. Women who take these medications should talk to their doctor before using Pregnitude.

About Everett Laboratories, Inc.

Everett Laboratories Inc. is a New Jersey-based women's healthcare pharmaceutical company that has been providing essential pharmaceutical and nutritional products for four decades. Everett Laboratories Inc. is a subsidiary of The Chemo Group, a global healthcare corporation based in Spain with a presence in more than 30 countries. The company recently licensed products for stress urinary incontinence, fertility, and the Stuart Natal line of pre-natal vitamins. Everett Laboratories Inc. is dedicated to providing advanced treatments and innovative new products to address unmet needs for women and families and to improving women's health. The company strives to produce and market unique, first-in-class prescription and over the counter medications.


'/>"/>
SOURCE Everett Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Georgia Reproductive Specialists Participates in Largest-Ever In Vitro Fertilization Clinical Trial in the World
2. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
3. Reproductive Partners Participates in New IVF Progesterone Delivery System Study
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. Reportlinker Adds Global Markets for Assisted Reproductive Devices 2009
6. Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program
7. IVF FLORIDA Reproductive Associates Partners with The University of Miami School of Medicine and Jackson Memorial Health
8. Serono Symposia International Foundation in Collaboration With ESHRE Announces Public Competition in Reproductive Medicine
9. INVOcell Study Results to be Reported at the Annual Meeting of The American Society of Reproductive Medicine
10. Reproductive Medicine Associates of NJ Receive Top National Award for Ground-Breaking IVF Research
11. LABS, Inc. Announces Alliance with Ambry Genetics to Expand Testing Solutions for the Reproductive Health Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)... India , January 18, 2017 According to a ... and by Application: Global Opportunity Analysis and Industry Forecast, 2014 - 2022," the ... to reach $1,127 million by 2022, growing at a CAGR of 8.26% from ... in terms of revenue. Continue Reading ... ...
(Date:1/18/2017)...  With an annual growth ranging from 6% to 10%, South East ... International Expo, March 22-24, 2017) serves the industry by fostering the regional discourse - ... Investment Forum ASEAN -- India ... conference content Enhanced business matchmaking program Roadshows ... ...
Breaking Medicine Technology:
(Date:1/18/2017)... ... January 18, 2017 , ... At Hallmark Nameplate, their commitment ... they have achieved certification to ISO 13485. This certification is another way they are ... date products and services that they need. , The ISO 13485 Certification is a ...
(Date:1/18/2017)... ... January 18, 2017 , ... Rollerblade®, the worldwide ... (ABT), an innovative braking system that allows skaters of all levels to stop ... the biggest concerns of beginner and intermediate skaters – learning how to brake ...
(Date:1/17/2017)... NY (PRWEB) , ... January 17, 2017 , ... Gym ... opening of a new showroom at South Dixie Hwy in Miami, FL. , “We ... at Gym Source. “The new innovative in-store concept is designed to give clients a ...
(Date:1/17/2017)... , ... January 17, 2017 , ... SunView Software’s Service ... for Innovation of the Year. , Each year, Pink Elephant recognizes a ... innovative approach to address a specific business problem or opportunity. The award highlights original ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Mirror Mirror ... earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice founder, ... part of this elite group of providers. , Produced by Zeltiq, CoolSculpting is ...
Breaking Medicine News(10 mins):